High dietary intake of unsaturated fatty acids is associated with improved insulin resistance - a cross-sectional study based on the NHANES database.
Dietary formulations
HOMA-IR
Insulin resistance
Triglyceride-glucose index
Unsaturated dietary fats
Journal
Lipids in health and disease
ISSN: 1476-511X
Titre abrégé: Lipids Health Dis
Pays: England
ID NLM: 101147696
Informations de publication
Date de publication:
05 Dec 2023
05 Dec 2023
Historique:
received:
03
09
2023
accepted:
30
11
2023
medline:
7
12
2023
pubmed:
6
12
2023
entrez:
5
12
2023
Statut:
epublish
Résumé
A moderate intake of unsaturated fatty acids (UFA) is associated positively with improved insulin resistance. The aim of this study was to investigate the relationship between the dietary intake of unsaturated fatty acids/total fats (UFA/TF) and insulin resistance. 15,560 participants were selected from the National Health and Nutrition Examination Survey (NHANES) database enrolled between March 2017 and 2020, and excluded those under 20 years of age, pregnant, or with missing data for key research items. Finally, 7,630 participants were included in the study. R software was used for data analysis that included: (1) general descriptive statistics; (2) comparison of differences in baseline information of three UFA/TF groups, namely low, medium, and high ratios; (3) calculation of the correlation between the UFA/TF ratio and markers of insulin resistance: triglyceride-glucose index (TyG) and homeostatic model assessment for insulin resistance (HOMA-IR); (4) stratification of the study subjects into two groups, with or without insulin resistance, using a cut-off value of HOMA-IR ≥ 2, followed by logistic regression analysis to examine the relationship between UFA/TF and insulin resistance status in the two groups; and (5) further stratification of the subjects according to age, gender, body mass index (BMI), race, total energy intake, total protein, total carbohydrate, total sugars, total dietary fiber, total fat, alcohol consumption, diabetes, hypercholesterolemia to analyze the impact of UFA/TF on insulin resistance status in different subgroups. (1) A high UFA/TF level was associated with a low TyG index and HOMA-IR [β (vs. TyG index) = -0.559, 95% CI: (-0.821~-0.297), P < 0.001; β (vs. HOMA-IR) = -0.742, 95% CI: (-1.083~-0.402), P < 0.001]. This negative relationship became more pronounced when UFA/TF exceeded 57.9% (i.e., the higher group). (2) Logistic regression analysis showed that a higher UFA/TF level was associated with a lower risk of developing insulin resistance [Q3 vs. Q1: 0.838 (95%CI: 0.709 ~ 0.991); P for trend = 0.038]. After adjusting for covariates such as gender, age, and BMI, this protective effect remained significant (P value < 0.05). (3) Analysis also showed that increased UFA/TF intake reduced the risk of developing insulin resistance (OR = 0.266, 95% CI: (0.075 ~ 0.946), P = 0.041). Subgroup analysis showed that although elevated UFA/TF intake showed no statistically significant difference in its effect in most subgroups, the large study population in this study provides valuable insights on potential changes. Increased UFA/TF intake may confer relatively greater benefits within specific subgroups, particularly among the elderly [Q3 age group, OR = 0.114, 95%CI: (0.012 ~ 1.078), P = 0.058], females [OR = 0.234, 95%CI: (0.041 ~ 1.333), P = 0.102], those with a BMI ≤ 25 kg/m²[OR = 0.191, 95%CI: (0.016 ~ 2.344), P = 0.196], and individuals without hypercholesterolemia [OR = 0.207, 95%CI: (0.042 ~ 1.013), P = 0.0519]. The impact of high UFA/TF levels within subgroups based on the presence or absence of coronary heart disease and stroke displayed contrasting trends. In those without coronary heart disease, there was a significant protective effect against insulin resistance [OR = 0.254, 95% CI: (0.07 ~ 0.929), P = 0.0384], while in the stroke subgroup, a significantly protective effect against insulin resistance was observed [OR = 0.002, 95%CI: (0 ~ 0.695), P = 0.0376]. A high dietary intake of UFA relative to total fat consumption could be a protective factor against the risk of developing insulin resistance.
Sections du résumé
BACKGROUND
BACKGROUND
A moderate intake of unsaturated fatty acids (UFA) is associated positively with improved insulin resistance. The aim of this study was to investigate the relationship between the dietary intake of unsaturated fatty acids/total fats (UFA/TF) and insulin resistance.
METHODS
METHODS
15,560 participants were selected from the National Health and Nutrition Examination Survey (NHANES) database enrolled between March 2017 and 2020, and excluded those under 20 years of age, pregnant, or with missing data for key research items. Finally, 7,630 participants were included in the study. R software was used for data analysis that included: (1) general descriptive statistics; (2) comparison of differences in baseline information of three UFA/TF groups, namely low, medium, and high ratios; (3) calculation of the correlation between the UFA/TF ratio and markers of insulin resistance: triglyceride-glucose index (TyG) and homeostatic model assessment for insulin resistance (HOMA-IR); (4) stratification of the study subjects into two groups, with or without insulin resistance, using a cut-off value of HOMA-IR ≥ 2, followed by logistic regression analysis to examine the relationship between UFA/TF and insulin resistance status in the two groups; and (5) further stratification of the subjects according to age, gender, body mass index (BMI), race, total energy intake, total protein, total carbohydrate, total sugars, total dietary fiber, total fat, alcohol consumption, diabetes, hypercholesterolemia to analyze the impact of UFA/TF on insulin resistance status in different subgroups.
RESULTS
RESULTS
(1) A high UFA/TF level was associated with a low TyG index and HOMA-IR [β (vs. TyG index) = -0.559, 95% CI: (-0.821~-0.297), P < 0.001; β (vs. HOMA-IR) = -0.742, 95% CI: (-1.083~-0.402), P < 0.001]. This negative relationship became more pronounced when UFA/TF exceeded 57.9% (i.e., the higher group). (2) Logistic regression analysis showed that a higher UFA/TF level was associated with a lower risk of developing insulin resistance [Q3 vs. Q1: 0.838 (95%CI: 0.709 ~ 0.991); P for trend = 0.038]. After adjusting for covariates such as gender, age, and BMI, this protective effect remained significant (P value < 0.05). (3) Analysis also showed that increased UFA/TF intake reduced the risk of developing insulin resistance (OR = 0.266, 95% CI: (0.075 ~ 0.946), P = 0.041). Subgroup analysis showed that although elevated UFA/TF intake showed no statistically significant difference in its effect in most subgroups, the large study population in this study provides valuable insights on potential changes. Increased UFA/TF intake may confer relatively greater benefits within specific subgroups, particularly among the elderly [Q3 age group, OR = 0.114, 95%CI: (0.012 ~ 1.078), P = 0.058], females [OR = 0.234, 95%CI: (0.041 ~ 1.333), P = 0.102], those with a BMI ≤ 25 kg/m²[OR = 0.191, 95%CI: (0.016 ~ 2.344), P = 0.196], and individuals without hypercholesterolemia [OR = 0.207, 95%CI: (0.042 ~ 1.013), P = 0.0519]. The impact of high UFA/TF levels within subgroups based on the presence or absence of coronary heart disease and stroke displayed contrasting trends. In those without coronary heart disease, there was a significant protective effect against insulin resistance [OR = 0.254, 95% CI: (0.07 ~ 0.929), P = 0.0384], while in the stroke subgroup, a significantly protective effect against insulin resistance was observed [OR = 0.002, 95%CI: (0 ~ 0.695), P = 0.0376].
CONCLUSION
CONCLUSIONS
A high dietary intake of UFA relative to total fat consumption could be a protective factor against the risk of developing insulin resistance.
Identifiants
pubmed: 38053162
doi: 10.1186/s12944-023-01982-1
pii: 10.1186/s12944-023-01982-1
pmc: PMC10696799
doi:
Substances chimiques
Fatty Acids, Unsaturated
0
Triglycerides
0
Dietary Carbohydrates
0
Blood Glucose
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
216Subventions
Organisme : Science and Technology Innovation 2030 Major Projects
ID : 2022ZD0211600
Informations de copyright
© 2023. The Author(s).
Références
Genomics Proteomics Bioinformatics. 2021 Oct;19(5):754-771
pubmed: 33631425
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1135-1147
pubmed: 32212849
Circulation. 2016 Jan 12;133(2):187-225
pubmed: 26746178
PLoS One. 2016 Feb 22;11(2):e0149033
pubmed: 26901315
Hypertension. 2018 Jun;71(6):e13-e115
pubmed: 29133356
Clin Chem Lab Med. 2021 Aug 11;59(11):1844-1851
pubmed: 34380182
Pol Arch Intern Med. 2018 Dec 21;128(12):755-763
pubmed: 30457128
Diabetes. 2016 Jun;65(6):1462-71
pubmed: 27222390
Food Nutr Res. 2014 Jul 10;58:
pubmed: 25045347
Int J Mol Sci. 2020 Sep 02;21(17):
pubmed: 32887221
Environ Int. 2018 Dec;121(Pt 1):340-348
pubmed: 30243182
J Am Heart Assoc. 2019 May 7;8(9):e011512
pubmed: 31039663
Mol Cell Endocrinol. 2014 Aug 5;393(1-2):129-42
pubmed: 24973767
Lipids Health Dis. 2022 Feb 10;21(1):20
pubmed: 35144649
Clin Nutr. 2018 Aug;37(4):1423-1429
pubmed: 28673690
Circulation. 2022 Jul 5;146(1):21-35
pubmed: 35422138
PLoS Med. 2016 Jul 19;13(7):e1002087
pubmed: 27434027
Adv Nutr. 2022 Oct 2;13(5):1584-1602
pubmed: 35170723
J Chromatogr A. 2002 Jan 18;943(2):299-302
pubmed: 11833650
Nat Commun. 2019 Sep 5;10(1):4007
pubmed: 31488836
Metabolism. 2021 Jun;119:154766
pubmed: 33766485
Vital Health Stat 1. 2022 May;(190):1-36
pubmed: 35593699
Sultan Qaboos Univ Med J. 2021 Nov;21(4):604-612
pubmed: 34888081
Am J Clin Nutr. 2020 Jul 1;112(1):150-167
pubmed: 32020162
BMJ. 1997 Jan 11;314(7074):112-7
pubmed: 9006469
J Nutr. 2022 Aug 9;152(8):1851-1861
pubmed: 35700149
Curr Opin Clin Nutr Metab Care. 2022 Nov 1;25(6):436-442
pubmed: 35943130
Sci Rep. 2022 Mar 3;12(1):3550
pubmed: 35241770
BMC Cardiovasc Disord. 2018 Oct 29;18(1):203
pubmed: 30373519
Front Nutr. 2023 Jan 10;9:1055923
pubmed: 36704786
Cardiovasc Diabetol. 2020 Jul 23;19(1):116
pubmed: 32703284
J Agric Food Chem. 2021 Aug 18;69(32):9178-9187
pubmed: 33560835
Cardiovasc Diabetol. 2020 Jun 13;19(1):80
pubmed: 32534586
JAMA. 2020 Dec 8;324(22):2268-2280
pubmed: 33190147
BMJ Open Diabetes Res Care. 2019 Feb 8;7(1):e000585
pubmed: 30899527
Br J Nutr. 2023 Oct 14;130(7):1121-1136
pubmed: 36688295
Int J Environ Res Public Health. 2019 Sep 26;16(19):
pubmed: 31561434
N Engl J Med. 2019 Jan 3;380(1):11-22
pubmed: 30415628
J Nutr Sci. 2023 May 08;12:e55
pubmed: 37180485
J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4531-e4541
pubmed: 34160623
Medicina (Kaunas). 2019 May 17;55(5):
pubmed: 31108989
Am J Clin Nutr. 2003 May;77(5):1146-55
pubmed: 12716665
Cardiovasc Diabetol. 2021 Feb 11;20(1):43
pubmed: 33573649
Metabolism. 2011 Nov;60(11):1551-9
pubmed: 21621801